Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Translational Pharmacology Research Fellowship
Kartha, R. (PI)
10/12/24 → 12/12/25
Project: Research project
-
Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
Kartha, R. (PI) & Subramanian, S. (CoI)
1/1/23 → 7/31/25
Project: Research project
-
Magnetic Resonance Spectroscopy Biomarkers in Type 3 Gaucher Disease
Kartha, R. (PI)
8/2/22 → 8/1/25
Project: Research project
-
NOVEL INFLAMMATORY BIOMARKERS COMPLEMENT 5A AND HEPCIDIN IN PATIENTS WITH GAUCHERDISEASE (GD)
Kartha, R. (PI)
3/23/21 → 8/5/25
Project: Research project
-
Use of Antioxidant or Anti-inflammatory Medications to Mitigate Oxidative Stress and Inflammation in Type1 Gaucher Disease (GD1)
Kartha, R. (PI) & Cloyd, J. C. (CoI)
8/1/18 → 12/31/25
Project: Research project
-
Emerging biomarkers in Gaucher disease
Luettel, D. M., Terluk, M. R., Roh, J., Weinreb, N. J. & Kartha, R. V., Jan 2025, Advances in Clinical Chemistry. Makowski, G. S. (ed.). Academic Press Inc., p. 1-56 56 p. (Advances in clinical chemistry).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in children
Wolthuis, D. F. G. J., Freriksen, J. J. M., ter Avest, M., Kartha, R. V., de Wildt, S. N., Wijnsma, K., van de Kar, N. C. A. J. & ter Heine, R., Jun 2025, In: Pediatric Nephrology. 40, 6, p. 2009-2019 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of Gene Therapies from an Academic Perspective
Kartha, R. V. & Orchard, P. J., Jan 1 2024, Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations. CRC Press, p. 351-368 18 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
Ahmed, M. A., Krishna, R., Rayad, N., Albusaysi, S., Mitra, A., Shang, E., Hon, Y. Y., AbuAsal, B., Bakhaidar, R., Roman, Y. M., Bhattacharya, I., Cloyd, J., Patel, M., Kartha, R. V. & Younis, I. R., Dec 2024, In: Clinical pharmacology and therapeutics. 116, 6, p. 1412-1432 21 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Intravital microscopy: An innovative approach to track real-time muscle integrity and pathology in Pompe disease
Pillai, N. R. & Kartha, R. V., Aug 2024, In: Clinical and Translational Discovery. 4, 4, e322.Research output: Contribution to journal › Comment/debate › peer-review
Open Access